The 9th Pharmaceutical
Powder X-ray Diffraction
22–25 February 2010
Hilton Head Island, South Carolina
Trying to reach the Pharmaceutical XRD Market?
Reserve your exhibit space at the 9th Pharmaceutical Powder X-ray Diffraction Symposium PPXRD-9
Complete details on exhibiting and sponsorships to promote your products and services to the pharmaceutical XRD market (PDF)
Understanding Amorphous Pharmaceutical Materials
Patent and Regulatory Issues
XRPD Structural Techniques (Acquisition and
Use of XRPD Data, Indexing, Structure
Determination, Rietveld Refinement)
Formulation & Product Development
Polymorph & Salt Screening
Amorphous, Activated, and Nanomaterials
New Frontiers in XRD in Pharmaceutical R&D
23-24 February 2010
Concurrent with the symposium and evening poster session and reception will be a commercial exhibition of analytical instrumentation and related products and services. Exhibitors are invited to inquire about exhibit reservations and sponsorship opportunities by contacting Denise Flaherty: firstname.lastname@example.org.
Dates to Remember:
Deadline for submission of abstracts: 30 November 2009
Deadline for Early Registration reduced rate: 30 December 2009
Deadline to register: 15 February 2010
Registration Cancellation: 8 February 2010
International Centre for Diffraction Data
Dr. Cyrus Crowder, Chair, International Centre for Diffraction Data, Newtown Square, PA, U.S.A.
Dr. Detlef Beckers, PANalytical, Almelo, The Netherlands
Dr. Harry G. Brittain, Center for Pharmaceutical Physics, Milford, NJ, U.S.A.
Dr. Julien Giovannini, AstraZeneca, Nottingham, U.K.
Dr. Arnt Kern, Bruker AXS GmbH, Karlsruhe, Germany
Terry Maguire, International Centre for Diffraction Data, Newtown Square, PA, U.S.A.
Dr. Fangling Needham, International Centre for Diffraction Data, Newtown Square, PA, U.S.A.
Dr. Kenneth Shankland, Reading University, Reading, U.K.
Dr. Gregory A. Stephenson, Eli Lilly and Company, Indianapolis, IN, U.S.A.
Dr. Raj Suryanarayanan, University of Minnesota, Minneapolis, MN, U.S.A.
Dr. Hideo Toraya, Rigaku Corporation, Tokyo, Japan
Dr. Peter G. Varlashkin, GlaxoSmithKline, Durham, NC, U.S.A.
Dr. Shawn Yin, Bristol-Myers Squibb Company, New Brunswick, NJ, U.S.A.
To receive a brochure, e-mail your mailing address to email@example.com